Tampa, Florida, United States - TheNewswire  -  April 25, 2022 - CTT Pharmaceutical Holdings, Inc. (OTC:CTTH) is announcing today that we have recently filed a patent application encompassing vitamin-containing orally administrable strips. The continuation-in-part application stems from our previously granted US Patent for similar orally administrable strips and is, thus, based on technology already determined to be patentable by the United States Patent and Trademark Office. The strips have been developed to deliver agents such as vitamins for absorption by the oral mucosa. This patent covers dissolvable strips containing vitamins from various sources.

CTT Pharma’s vitamin strips dissolve in your mouth in seconds, then enters the bloodstream, bypassing the digestive tract including the liver. This allows for fast onset, better absorption/bioavailability, and the ability to add/combine actives to our Vitamin strips, such as CBD, and Caffeine for example. CTT can also make our strips with any color and any flavor.

“Strengthening our vitamin patent portfolio was an important step for CTT. I look at our dissolvable vitamin strips as the next evolution to traditional vitamin pills and gummies. Furthermore, CTT will look to monetize our patent pending technology with a company in the United States by engaging nutraceutical companies about our vitamin strips.” said Ryan Khouri, CEO of CTT Pharma.

CTT Pharma will continue to update our shareholders as more news becomes available.

Ryan Khouri - 813-606-0060 

www.linkedin.com/in/ryan-khouri-679a251b7

www.cttpharmaceuticals.com